Metaplanet

VC Tallinn, Estonia · Founded 2011

Metaplanet makes long-term investments in deep technology and life sciences that promise lasting positive impacts on society and civilization. The firm prioritizes mission-driven founders working on disruptive innovations, particularly those mitigating existential risks or advancing synthetic biology and AI.

About Metaplanet

Metaplanet, in its venture form, has historically been associated with Roko Mijic and a thesis that blends frontier technology, biotech, and ambitious moonshot investing rather than conventional early-stage software venture; the same name has separately become well-known as a Japanese listed company pursuing a bitcoin-treasury strategy, which can muddle public perception. Healthcare and life-sciences founders should focus on the venture-investing arm if that is the intended counterparty and confirm carefully which entity they are speaking with. Healthcare exposure within the venture vehicle is consistent with a deep-tech orientation, including longevity, biotech tools, and AI-for-science companies, rather than payor or provider software. AI focus is genuine and central in that frame, with interest in AI-for-biology and AI-for-science where the underlying technical bet is unusual. Stage is typically pre-seed and seed, with checks plausibly in the USD 100K to USD 500K range deployed alongside other deep-tech specialists. This is the wrong door for digital health, telemedicine, or healthcare services. It is a fit for founders pursuing genuinely ambitious, technically dense bets in longevity, biology automation, and AI-for-science where conviction matters more than incremental milestones. Entry path is direct outreach through the website and, more reliably, warm introductions through the deep-tech and longevity research communities. Founders should be ready to defend the technical core in detail; thesis-only pitches will be unwelcome.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Metaplanet

Tools made by companies in Metaplanet's portfolio that we cover in the directory.

Loss of Pulse Detection
Fitbit
Cardiology AI
Fitbit's Loss of Pulse Detection is an FDA-cleared feature on compatible wearable devices that uses PPG and accelerometry to detect a potential loss of pulse and can automatically alert emergency services if the user is unresponsive.
KelaHealth Surgical Intelligence
KelaHealth
Clinical Decision Support & Reference
Delivers patient-specific predictive insights and risk stratification using AI and machine learning to improve surgical care quality and clinical operations.

Portfolio companies in our directory

Other portfolio companies

Companies in Metaplanet's portfolio not currently in our directory.

Team

Jaan Tallinn
Founder
Rauno Miljand
Managing Partner
Sven Bu00f6ttcher
General Counsel

Pitch / review this investor

Have you raised from Metaplanet? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.